Anaphylaxis during anesthesia in France: An 8-year national survey

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 2, 2011, Pages 366-373

  Mertes, Paul Michel ^a   Alla, François ^a   Tréchot, Philippe ^a   Auroy, Yves ^b   Jougla, Eric ^c   Cottineau, C ^d   Drouet, M ^d   Girardin, P ^d   Koeberle P ^d   Vigan, M ^d   Guez, S ^d   Maurette, P ^d   Rakotoseheno, J C ^d   Laroche, D ^d   Vergnaud, M C ^d   Scherer, P ^d   Herbin, D ^d   Outtas, O ^d   Theissen Laval, O ^d   Deschamps, B ^d   Collet, E ^d   Louvier, N ^d   Seltzer, S ^d   Duffin, B ^d   Beaudoin, E ^d   Dugue P ^d   Honarmand Pepin, M ^d   Jacquot, C ^d   Castelain Hacquet, C ^e   Fessenmeyer, C ^d   Facon, A ^f   Orsel, I ^d   Sainte Laudy, J ^d   Bernard, C ^d   Benoit Y ^d   Diot Junique, N ^d   Dubost, J ^d   Dubost, R ^d   Guilloux, L ^d   Topenot, I ^d   Birnbaum, J ^d   Vervloet D ^d   Demoly, P ^d   Bonnet Boyer, M C ^d   Gastin, I ^d   Gueant J L ^d   Laxenaire, M C ^d   Mertes, P M ^d   Kanny, G ^d   Moneret Vautrin, D A ^d   Mouton, C ^d   Decagny, S ^d   Pinaud, M ^d   Wessel, F ^d   Gallen, C ^d   Aguinet, E ^d   Leroy, S ^d   Occelli, G ^d   Joncourt, M ^d   Delalande, J P ^d   Lemaire, B ^d   Mfam, W S ^d   Chollet Martin, S ^d   Neukirch, C ^d   Nicaise Roland, P ^d   Sauvan Pistof, C ^d   Korinek, A M ^d   Karila, C ^d   Guinnepain, M T ^d   Bellanger, M ^d   Dona, M ^d   Seringulian, A ^d   Megret Gabeaud, M L ^d   Abuaf, N ^d   Gaouar, H ^d   Antegarden, J E ^d   Leynadier, F ^d   Breuil, K ^d   Grandon, L ^d   Gallet Browaeys, A ^d   Lavaud, F ^d   Malinovsky, J M ^d   Delaval, Y ^d   Lucas, M M ^d   Rochefort Morel, C ^d   Meunier, Y ^d   Provost, D ^d   Dzviga, C ^d   Mangin, M ^d   Mallet, J P ^d   Stenger, R ^d   Le Borgne, S ^d   Valfrey, J ^d   Gayraud, J ^d   Didier, A ^d   Giamarchi, D ^d   Migueres, I ^d   Carre P ^d   more..

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Hôpital d'Instruction des Armées Val de Grâce   (France)

^c INSERM   (France)

^d Hôpital d'Instruction des Armées Val de Grâce ^*

^e Institut Catholique De Lille (ICL)   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Anaphylaxis; anesthesia; antibiotics; children; epidemiology; latex; neuromuscular blocking agents; sex

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; ATRACURIUM; BUPIVACAINE; CEPHALOSPORIN; CISATRACURIUM; FENTANYL; HYPNOTIC AGENT; IMMUNOGLOBULIN E; KETAMINE; LATEX; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; MIVACURIUM; MORPHINE; NALBUPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PANCURONIUM; PENICILLIN G; PROPACETAMOL; PROPOFOL; PROTAMINE; REMIFENTANIL; ROCURONIUM; SUFENTANIL; SUXAMETHONIUM; UNINDEXED DRUG; VECURONIUM;

ADULT; ANAPHYLAXIS; ANESTHESIA; ARTICLE; CLINICAL PRACTICE; COLLOID; CONTROLLED STUDY; DATA BASE; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; HYPERSENSITIVITY REACTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 79961034138     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.03.003     Document Type: Article

References (52)

1. Auroy Y, Benhamou D, Pequignot F, Bovet M, Jougla E, Lienhart A. Mortality related to anaesthesia in France: analysis of deaths related to airway complications. Anaesthesia 2009;64:366-70.
2. Haller G, Stoelwinder J, Myles PS, McNeil J. Quality and safety indicators in anesthesia: a systematic review. Anesthesiology 2009;110:1158-75.
3. Wubben I, van Manen JG, van den Akker BJ, Vaartjes SR, van Harten WH. Equipment-related incidents in the operating room: an analysis of occurrence, underlying causes and consequences for the clinical process. Qual Saf Health Care 2010;19:1-7.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5. (Pubitemid 28193431)
5. Pirmohamed M, Park BK. Adverse drug reactions: back to the future. Br J Clin Pharmacol 2003;55:486-92. (Pubitemid 36645404)
6. Tsong Y. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting. J Biopharm Stat 1995;5:95-114.
7. Laake JH, Rottingen JA. Rocuronium and anaphylaxis-a statistical challenge. Acta Anaesthesiol Scand 2001;45:1196-203.
8. Mertes PM, Guttormsen AB, Harboe T, Johansson SG, Florvaag E, Husum B, et al. Can spontaneous adverse event reporting systems really be used to compare rates of adverse events between drugs? Anesth Analg 2007;104:471-2.
9. Jonville-Béra AP, Autret E. [Application of the capture/recapture method to spontaneous reporting in drug surveillance]. Thérapie 1996;51:169-75.
10. Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br J Clin Pharmacol 2006;62:225-31. (Pubitemid 44321384)
11. Seeger JD, Schumock GT, Kong SX. Estimating the rate of adverse drug reactions with capture-recapture analysis. Am J Health Syst Pharm 1996;53:178-81.
12. Laxenaire M, Mertes PM, GERAP. Anaphylaxis during anaesthesia: results of a 2 year survey in France. Br J Anaesth 2001;21:549-58. (Pubitemid 32936731)
13. Laxenaire MC. Substances responsible for peranesthetic anaphylactic shock: a third French multicenter study (1992-94). Ann Fr Anesth Reanim 1996;15:1211-8.
14. Laxenaire MC. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999;18:796-809.
15. Laxenaire MC, Moneret-Vautrin DA, Vervloet D. The French experience of anaphylactoid reactions. Int Anesthesiol Clin 1985;23:145-60. (Pubitemid 15020709)
16. Laxenaire MC, Moneret-Vautrin DA, Widmer S, Mouton C, Gueant JL, Bonnet MC, et al. Anesthetics responsible for anaphylactic shock: a French multicenter study. Ann Fr Anesth Reanim 1990;9:501-6.
17. Mertes PM, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France: seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004;23:1133-43.
18. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45.
19. Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000;320:1036. (Pubitemid 30198972)
20. Clergue F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire MC. French survey of anesthesia in 1996. Anesthesiology 1999;91:1509-20.
21. Mertes PM, Laxenaire MC, Lienhart A, Aberer W, Ring J, Pichler WJ, et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 2005;15:91-101. (Pubitemid 41020169)
22. Reducing the risk of anaphylaxis during anaesthesia. (Short text.) Ann Fr Anesth Reanim 2002;21(suppl 1):7s-23s.
23. Mertes PM, Moneret-Vautrin DA, Leynadier F, Laxenaire MC. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 2007;107:245-52. (Pubitemid 47196487)
24. Gueant JL, Mata E, Monin B, Moneret-Vautrin DA, Kamel L, Nicolas JP, et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991;46:452-8.
25. Guilloux L, Ricard-Blum S, Ville G, Motin J. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992;90:153-9.
26. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6. (Pubitemid 38608590)
27. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-24. (Pubitemid 32800388)
28. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985;2:1056-8. (Pubitemid 16206749)
29. Le Panel Hospitalier, MAPI. Lyon: Edition Domaine Medical; 2004.
30. Fishman G, editor. Monte-Carlo concepts, algorithms, and applications. New York: Springer; 1996.
31. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993;12:97-104. (Pubitemid 23176406)
32. Adkinson NF Jr, Essayan D, Gruchalla R, Haggerty H, Kawabata T, Sandler JD, et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol 2002;109:S461-78.
33. Sachs RM, Bortnichak EA. An evaluation of spontaneous adverse drug reaction monitoring systems. Am J Med 1986;81:49-55.
34. Arnold R, Hayakawa Y, Yip P. Capture-recapture estimation using finite mixtures of arbitrary dimension. Biometrics 2010;66:644-55.
35. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008;63:1418-27.
36. Mertes PM, Tajima K, Regnier-Kimmoun MA, Lambert M, Iohom G, Gueant-Rodriguez RM, et al. Perioperative anaphylaxis. Med Clin North Am 2010;94: 761-89, xi.
37. Florvaag E, Johansson SG. The pholcodine story. Immunol Allergy Clin North Am 2009;29:419-27.
38. Gerber BO, Pichler WJ. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J 2006;8:160-5.
39. Lang TJ. Estrogen as an immunomodulator. Clin Immunol 2004;113:224-30. (Pubitemid 39422599)
40. Uemura Y, Liu TY, Narita Y, Suzuki M, Matsushita S. 17 Beta-estradiol (E2) plus tumor necrosis factor-alpha induces a distorted maturation of human monocyte-derived dendritic cells and promotes their capacity to initiate T-helper 2 responses. Hum Immunol 2008;69:149-57.
41. Jensen-Jarolim E, Untersmayr E. Gender-medicine aspects in allergology. Allergy 2008;63:610-5. (Pubitemid 351490402)
42. Mitchell VL, Gershwin LJ. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin Exp Allergy 2007;37:276-86. (Pubitemid 46148286)
43. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, et al. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 2007;44:1977-85.
44. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983;306:262-4. (Pubitemid 14232353)
45. Fisher M. Anaphylaxis to anaesthetic drugs. Novartis Found Symp 2004;257:193-202.
46. Mertes PM, Aimone-Gastin I, Gueant-Rodriguez RM, Mouton-Faivre C, Audibert G, O'Brien J, et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 2008;14:2809-25.
47. Florvaag E, Johansson SG, Oman H, Venemalm L, Degerbeck F, Dybendal T, et al. Prevalence of IgE antibodies to morphine: relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005;49:437-44. (Pubitemid 40488565)
48. Johansson SG, Florvaag E, Oman H, Poulsen LK, Mertes PM, Harper NJ, et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 2010;65:498-502.
49. Cremer R, Kleine-Diepenbruck U, Hering F, Holschneider AM. Reduction of latex sensitisation in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg 2002;12:S19-21.
50. De Queiroz M, Combet S, Berard J, Pouyau A, Genest H, Mouriquand P, et al. Latex allergy in children: modalities and prevention. Paediatr Anaesth 2009;19:313-9.
51. Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004;27:393-410. (Pubitemid 38608458)
52. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54.